Maple syrup urine disease: Role of diffusion-weighted magnetic resonance imaging by Narra, Ramakrishna et al.
Vol 4 | Issue 6 | Nov - Dec 2018 Indian J Case Reports 463
Case Report
Maple syrup urine disease: Role of diffusion-weighted magnetic resonance 
imaging
Ramakrishna Narra1, P Bhimeswara Rao2, B Johny Prasad3, Anusha Putcha4
From 1Additional Professor, 2Professor, 3Assistant Professor, 4Junior Resident, Department Radio Diagnosis, Katuri Medical College, Guntur, 
Andhra Pradesh, India
Correspondence to: Dr. Ramakrishna Narra, Flat No: 30, 5 Floor, Venkatesh Estate Apartment ½ Chandramouli Nagar, Guntur - 522 006, 
Andhra Pradesh, India. E-mail: narra.ramki29@gmail.com
Received - 13 October 2018 Initial Review - 26 October 2018 Accepted - 16 November 2018
Maple syrup urine disease (MSUD) is a rare autosomal recessive condition. It is a disorder of branched-chain amino acids (leucine, isoleucine, and valine) 
metabolism, which occurs due to the deficiency of branched-
chain alpha-ketoacid decarboxylase complex. Accumulation 
of branched-chain ketoacid causes disruption of Krebs cycle, 
displaces other essential amino acids, causing neurotransmitter 
depletion, and resulting in disrupted brain growth and 
development [1]. The estimated worldwide incidence of MSUD 
is 1 in 185,000 infants [2]. Diffuse, bilateral symmetrical edema 
involving the cerebellum, brainstem, globus pallidus, thalami, 
cerebral peduncles, and corticospinal tracts with marked diffusion 
restriction on diffusion-weighted magnetic resonance imaging 
(DWI) and reduced apparent diffusion coefficient (ADC) values 
are the most common findings on magnetic resonance imaging 
(MRI) in MSUD.
CASE REPORT
A 1-year, 2-month-old male child, born to non-consanguineous 
parents, presented with complaints of unable to hold the neck 
of child and foul smelling of urine since birth. The child 
was unable to recognize his mother and there were feeding 
difficulties, especially to solid, semi-solid food, and pooling 
of secretions were also present. The antenatal period was 
uneventful with normal vaginal delivery in a hospital at term 
gestation. History of neonatal seizures was present at day 4 
of life since then; the child was on sodium valproate therapy. 
The child was on bottle feeding from day 4 to day 25 of life. 
The child also had breath holding spells from 4 months of 
age and he has not attained the following milestones: Social 
smile, stable head control, sitting without support, standing, 
and speech milestones. The global developmental delay was 
present, and in his family history, sibling of the child’s mother 
had similar complaints.
On physical examination, general condition of the patient 
was good and vitals were stable: Respiratory rate=24/min 
(normal=20–30/min), pulse rate=92/min (normal=80–130/min), and 
blood pressure=90/60 mmHg (normal=86–106/422–63 mmHg). 
On systemic examination, hypotonia was present in all four limbs; 
power was 2/5 and gait was absent.
MRI of the brain revealed the following: Hyperintense 
signal on DWI and a hypointense signal on ADC indicating 
diffusion restriction on DWI and reduced ADC values were 
noted in bilateral perirolandic white matter (Fig. 1), thalami, 
internal capsules (Fig. 2), brainstem, and cerebellar dentate 
nuclei (Fig. 3). Diffuse T2W (Fig. 4) and fluid-attenuated 
inversion recovery (Fig. 5) hyperintense signal noted in 
bilateral fronto-parieto-occipital white matter, thalami, 
internal capsules, brainstem, and cerebellar dentate nuclei. 
Hence, based on the clinical and imaging findings, the possible 
differentials considered were MSUD and hypoxic-ischemic 
encephalopathy.
Laboratory investigations revealed elevated plasma 
levels of leucine=185.53 mmol/L (normal=47–155 mmol/L), 
isoleucine=127.52 mmol/L (normal=31–86mmol/L), and 
valine=357.78 mmol/L (normal=62–294 mmol/L) and positive 
dinitrophenylhydrazine screening test of urine, thus confirming 
the diagnosis of MSUD. Treatment was initiated in the form of 
protein-restricted diet and intravenous glucose on follow-up, 
there was a symptomatic improvement.
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DISCUSSION
In MSUD, intracellular (cytotoxic) edema affects the myelinated 
white matter involving cerebellar white matter, brainstem, globus 
pallidus, thalami, cerebral peduncles, and corticospinal tracts in 
the brain. MSUD is divided into four major categories: Classic, 
intermediate, intermittent, and thiamine responsive [3].
In a study by Cheng et al., 10 MSUD patients had the classic 
form of MSUD with DCKBHB mutation is more common 
with significant brain injury on MRI [4]. Age, at presentation, 
was 2–3 days of life with feeding difficulty, poor weight gain, 
lethargy, and irritability [5]. Classic form has a lifelong risk of 
metabolic decompensation and has little or no residual enzymatic 
activity, whereas the intermediate form has greater enzymatic 
activity. Age at presentation, in an intermediate form, ranges from 
5 months to 7 years with symptoms such as seizures, neurological 
dysfunction, and global developmental delay. An intermittent form 
of MSUD is characterized by maple syrup or burnt sugar smell of 
urine and sweat, ataxia, and lethargy. Patients with intermittent 
form have normal growth and intellectual development. 
Thiamine-responsive form of MSUD has symptoms similar to the 
intermediate form and these patients respond to treatment with 
thiamine (Vitamin B1) [6].
Acute encephalopathy and coma are the rare presenting 
features. Neurological symptoms in MSUD are due to the rapid 
accumulation of leucine in particular. Increased plasma levels of 
isoleucine are associated with maple syrup odor of urine.
Non-contrast CT of the brain shows diffuse bilaterally 
symmetrical edema not sparing brainstem and cerebellum [7]. 
On T1W MRI, MSUD edema shows hypointense signal with 
sharp margins. On T2W MRI, edema shows hyperintense signal, 
Figure 1: (a) Diffusion-weighted imaging (DWI) image showing 
restriction in bilateral perirolandic white matter (arrows), 
(b) Apparent diffusion coefficient (ADC) map showing reduced ADC 
values in bilateral perirolandic white matter (arrows)
a b
Figure 2: (a) Diffusion-weighted imaging image showing restriction 
in bilateral internal capsules (arrows) and thalami, (b) apparent 
diffusion coefficient (ADC) map showing reduced ADC values in 
bilateral internal capsules and thalami (arrows)
a b
Figure 3: (a) Diffusion-weighted imaging image showing restriction 
in brainstem and cerebellar dentate nuclei (arrow), (b) apparent 
diffusion coefficient (ADC) map showing reduced ADC values in 
brainstem (arrow) and cerebellar dentate nuclei
a b
Figure 4: (a) T2W magnetic resonance (MR) image showing 
hyperintense signal in bilateral fronto-parieto-occipital white matter, 
thalami, internal capsules, (b) T2W MR image showing hyperintense 
signal in brainstem and cerebellar dentate nuclei (arrow)
a b
Figure 5: (a) Fluid-attenuated inversion recovery (FLAIR) magnetic 
resonance (MR) image showing hyperintense signal in bilateral 
fronto-parieto-occipital white matter, thalami, internal capsules, 
(b) FLAIR MR image showing hyperintense signal in brainstem and 
cerebellar dentate nuclei
a b
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which disappears in late stages. DWI shows a marked restriction 
with reduced ADC values, which indicates MSUD edema is 
an intracellular edema. DWI is the most sensitive imaging 
tool in detecting MSUD brain alterations, for early diagnosis 
and follow-up of metabolic diseases in neonates [8]. DWI is 
particularly useful in the unmyelinated brain where T2W imaging 
findings may be masked.
In a study done by Jan et al., they observed that in case of 
metabolic decompensation in MSUD the restriction of diffusion 
on DWI due to intramyelinic edema and elevated lactate, 
branched-chain amino acids on MR spectroscopy are reversible 
after metabolic correction [9].
On MR spectroscopy, abnormal branched-chain alpha-
ketoacid peak was obtained at 0.9 ppm and elevated lactate was 
the finding obtained in MSUD. In metabolic decompensated 
MSUD, the changes in cell osmolarity and metabolism can 
reverse completely after metabolic correction with clinical 
neurological improvement [10,11]. Apart from neuroimaging, 
other diagnostic methods include tandem mass spectroscopy 
which is a screening method in newborns for amino acids in 
blood [12]. Urine analysis for the detection of elevated levels 
of the branched-chain amino acids is done. Molecular diagnosis 
was done for the detection of mutations in BCKDHA, BCKDHB, 
and DBT genes for confirmation of the diagnosis. Enzymatic 
analysis of white blood cells and DNA testing is other rarely used 
diagnostic modalities.
Imaging differential diagnosis of MSUD is hypoxic-ischemic 
encephalopathy. However, restriction of diffusion on DWI is more 
intense in MSUD compared to hypoxic-ischemic encephalopathy. 
Management of MSUD includes protein-restricted diet, thiamine 
therapy as a trial to determine the form of MSUD. In case of 
metabolic crisis, hemodialysis/hemofiltration and intravenous 
glucose administration are done.
CONCLUSION
MR with DWI is the best imaging tool during hyperacute and acute 
phases of MSUD, for early diagnosis and follow-up, particularly 
in the unmyelinated brain where T2W imaging findings may be 
masked.
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